Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06173856
Other study ID # KAU-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2022
Est. completion date January 15, 2023

Study information

Verified date December 2023
Source Fatima Jinnah Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Raised serum bilirubin levels can cause kernicterus and premature infants are at increased risk due to metabolic immaturity. The standard treatment for neonatal jaundice is phototherapy but probiotics along with it can reduce the duration of phototherapy and hospitalization stay, secondarily can reduce the risk of nosocomial infection.


Description:

Raised serum bilirubin levels can cause kernicterus and premature infants are at increased risk due to metabolic immaturity. The comparative analytical study was conducted after the ethical approval for one year (Jan 2022-Jan 2023) in the neonatal unit of The University of Lahore Teaching Hospital, Lahore, Pakistan. 76 preterm neonates fulfilling the selection criteria were included in the study and divided into two groups. Standard phototherapy was applied in both groups and group A probiotic (Saccharomyces boulardii) 125mg, twice daily, orally (in 5cc of milk whichever the baby was taking) was given till discharge from the hospital. The primary outcome measurements were the duration of phototherapy and the length of hospitalization.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date January 15, 2023
Est. primary completion date October 10, 2022
Accepts healthy volunteers No
Gender All
Age group 0 Hours to 1 Week
Eligibility Inclusion Criteria: - All the Neonates with indirect hyperbilirubinemia, - Born at ;37 weeks of gestation - Both male and female neonates were included in the study Exclusion Criteria: - Neonates with sepsis, - bilirubin level in exchange transfusion range - direct hyperbilirubinemia - Neonates with respiratory distress syndrome, severe birth asphyxia, intubated and critically sick

Study Design


Related Conditions & MeSH terms


Intervention

Other:
LED phototherapy
LED phototherapy (430-470nm) alone will be applied.

Locations

Country Name City State
Pakistan Humaira Waseem Lahore

Sponsors (1)

Lead Sponsor Collaborator
Fatima Jinnah Medical University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary effectiveness mean duration of phototherapy and the mean duration of hospital stay with and without probiotics for treatment of indirect hyerbilirubinemia in preterm neonates probiotics for the treatment of indirect hyperbilirubinemia in preterm neonates 1 to 2 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04868019 - Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial N/A
Completed NCT00114543 - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight Phase 3
Completed NCT02000830 - Follow up Study of Patients Having Participated in Clinical Trial 64,185-204
Completed NCT01887327 - Stannsoporfin With Light Therapy for Newborn Babies With Jaundice Phase 2
Completed NCT05356273 - The Effect of Massage on the Bilirubin Level in Term Infants Receiving Phototherapy N/A
Suspended NCT03741803 - Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice N/A
Recruiting NCT03876678 - The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia N/A
Not yet recruiting NCT05365984 - Intelligent Follow-up of Neonatal Jaundice Based on Early Indicators and Internet Communications N/A
Recruiting NCT04251286 - Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
Completed NCT03723005 - A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns
Recruiting NCT06087874 - Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice Phase 2
Completed NCT03624335 - Influence of Umbilical Cord Clamping Time in the Newborn N/A
Recruiting NCT06324799 - The Effect of Position Change Frequency on Hyperbilirubinemia N/A
Recruiting NCT06209489 - White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns N/A
Completed NCT03824990 - Multi-center Clinical Study on Neonatal Hyperbilirubinemia N/A
Withdrawn NCT01330667 - Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia N/A
Completed NCT01169740 - Transcutaneous Measurement of Jaundice in the Newborn N/A
Recruiting NCT06238349 - Hyperbilirubinemia in Full-term Neonates Phase 4
Completed NCT03007563 - Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice N/A
Completed NCT01763632 - Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants N/A